U.S. Stock News

Wondering whether Sonic Automotive's current share price lines up with its underlying value, or if the recent attention has run ahead of the fundamentals? The stock last closed at US$76.43, with returns of 6.4% over 7 days, 17.1% over 30 days, 24.0% year to date, 24.5% over 1 year, 101.2% over 3 years and 64.1% over 5 years. These figures may catch the eye of investors reviewing performance over different time frames. Recent coverage of US auto retailers has focused on how dealers are...

Cal-Maine Foods recently reported quarterly revenue of US$667.00 million, a very large year-on-year decrease tied to lower egg prices, alongside a reduced variable dividend and an ongoing Department of Justice investigation into egg pricing. Despite these pressures, the company still exceeded analyst revenue expectations and attracted a new US$112.50 million position from River Road Asset Management, highlighting institutional interest in its diversified egg portfolio and cost...

ABM Industries recently announced that Vanderbilt University selected it to deliver its end-to-end ABM Performance Solutions model for the institution’s New York City campus, overseeing operations from renovation and startup through ongoing maintenance across cleaning, engineering, grounds, subcontract management, and event support. At the same time, filings showed that Vanguard entities now hold passive stakes of about 7% and 5% in ABM, highlighting continued institutional interest even as...

If you are wondering whether Definium Therapeutics at around US$21.70 still offers value after a strong run, this review of its pricing is designed to help you frame that question clearly. The stock has delivered a 59.1% return year to date and a 213.1% return over the last year, with shorter term moves including a 5.3% return over 30 days and a 3.5% decline over the past week. These swings sit against a longer track record where the 3 year return is very large at roughly 7x, while the 5...

Organon (NYSE:OGN) has agreed to be acquired by Sun Pharmaceutical Industries in an all cash deal valued at about $11.75b. The transaction is expected to close in early 2027, after which Organon is set to be delisted from the NYSE. Separately, Organon and Henlius have received European marketing approval for POHERDY, the first biosimilar to PERJETA. For investors watching NYSE:OGN, these developments arrive after a sharp recent move in the share price. The stock closed at $13.29, with...

Warrior Met Coal (HCC) opened Q1 2026 with total revenue of US$458.6 million and basic EPS of US$1.37, alongside net income of US$72.3 million, as the market weighs these fresh numbers against a current share price of US$86.20. Over the last six reported quarters, the company has seen quarterly revenue move from US$297.5 million in Q4 2024 to US$302.6 million in Q1 2025 and then to US$458.6 million in Q1 2026. Basic EPS shifted from US$0.02 in Q4 2024 to a loss of US$0.16 in Q1 2025 and then...

With FMC shares back at US$14.82, many investors are asking the same question: is the current price a rare value opportunity or a sign to stay cautious? Over the last week the stock slipped 0.4%, extended to a 13.6% decline over the past month, while still showing a 3.3% gain year to date against a much steeper 59.1% loss over the past year and an 85.6% and 85.3% decline over the last 5 and 3 years respectively. Recent market attention has focused on the scale of FMC's multi year share price...

In recent weeks, HEICO reported strong revenue and earnings growth supported by solid free cash flow, while benefiting from expanding demand across commercial aviation and defense and advancing its role in programs such as NASA's Artemis II mission. Insider purchases of about US$1.0 million in shares and the company's active acquisition program highlight internal confidence and an effort to broaden HEICO's aerospace and electronics footprint. Now, we'll explore how HEICO's...

In late April 2026, Element Solutions Inc reported first-quarter 2026 results showing sales rising to US$840 million from US$593.7 million a year earlier, while net income fell to US$55.9 million from US$98 million and diluted EPS from continuing operations decreased to US$0.23 from US$0.40. The quarter was marked by double-digit organic growth in the Electronics segment, strong contributions from the newly acquired Micromax and EFC businesses, and a higher full-year adjusted EBITDA guidance...

Ryman Hospitality Properties (RHP) started 2026 with Q1 revenue of $664.6 million and basic EPS of $1.12, alongside trailing twelve month revenue of $2.6 billion and EPS of $4.01 that frame the latest quarter in a broader context. Over the past year, revenue has moved from $2.3 billion in the 2024 Q4 trailing period to $2.6 billion in the latest trailing snapshot, while basic EPS has tracked between $4.54 and $4.01 over those same intervals. This gives investors a clearer view of the earnings...

If you are wondering whether PENN Entertainment's current share price still reflects good value, the recent performance and valuation checks give you a useful starting point. The stock last closed at US$17.27, with returns of 0.2% over 7 days, 15.1% over 30 days, 16.3% year to date, 8.1% over 1 year, and longer term declines of 34.7% over 3 years and 80.1% over 5 years that many investors will be weighing up. Recent coverage has focused on PENN Entertainment's position in the wider U.S...

In late April 2026, VSE Corporation sought stockholder approval to amend its Restated Certificate of Incorporation to authorize 10,000,000 shares of blank check preferred stock, aiming to enhance capital flexibility for M&A, capital structure optimization, and tailored investor financing ahead of a May 7, 2026 meeting. The proposal’s built-in safeguards, such as no preset superior voting rights, no current issuance plans, and required majority approval of all outstanding shares, highlight...

Q1 2026 earnings snapshot for SPS Commerce (SPSC) SPS Commerce (SPSC) has opened 2026 with Q1 revenue of US$192.1 million, basic EPS of US$0.53 and net income of US$19.7 million, providing new information for shareholders watching the US$58.92 share price. Over recent periods, the company has reported revenue of US$170.9 million in Q4 2024 and US$192.1 million in Q1 2026, while trailing twelve month EPS is US$2.41 on net income of US$90.9 million. With earnings and margins already central to...

What recent price moves say about Essential Utilities Essential Utilities (WTRG) has seen its share price soften recently, with a 0.4% decline in the past day, 3.8% over the past week, and a 6.4% drop over the past month. See our latest analysis for Essential Utilities. That recent 6.4% 30 day share price return, alongside a 1.6% share price decline year to date and a 3.3% fall in the 1 year total shareholder return, suggests momentum has been fading both in the short term and over a longer...

Agnico Eagle Mines (NYSE:AEM) opened 2026 with Q1 revenue of US$4.1b and basic EPS of US$3.39, against a trailing twelve month revenue base of US$13.5b and EPS of US$10.66 that reflects strong earnings growth of 126.1% over the past year. Over recent quarters, revenue has moved from US$2.2b in Q4 2024 to US$2.5b, US$2.8b, US$3.1b and US$3.6b in 2025, before reaching US$4.1b in Q1 2026. Basic EPS has stepped from US$1.02 to US$1.62, US$2.13, US$2.10, US$3.04 and now US$3.39, with trailing net...

Bio-Rad Laboratories (BIO) opened 2026 with Q1 revenue of US$592.1 million and a basic EPS loss of US$19.55, in a quarter where trailing twelve month EPS stood at US$6.24 on revenue of US$2.59 billion. The company has seen quarterly revenue move from US$585.4 million and EPS of US$2.29 in Q1 2025 to US$592.1 million and EPS of US$19.55 loss in Q1 2026. Over the same period, trailing twelve month net income shifted from a loss of US$2.16 billion in Q1 2025 to a profit of US$168.8 million in Q1...

Atlassian (TEAM) just posted Q3 2026 results with revenue of US$1.8 billion, a basic EPS loss of US$0.38 and net income loss of US$98.4 million, setting the tone for another quarter where growth and profitability remain in tension. The company has seen quarterly revenue move from US$1.36 billion in Q3 2025 to US$1.79 billion in Q3 2026. Over that span, basic EPS ranged from a loss of US$0.27 in Q3 2025 to a loss of US$0.38 in the latest quarter, leaving investors focused squarely on how...

Corvus Pharmaceuticals (CRVS) has drawn investor attention after appointing immunologist and drug development leader Dr. Andrew C. Chan to its Board of Directors. The move highlights the company’s focus on research driven decision making. See our latest analysis for Corvus Pharmaceuticals. The latest share price of US$15.46 comes after a mixed few months, with a 7.1% 30 day share price return set against a 25.3% decline over 90 days. At the same time, a year to date share price return of...

If you are wondering whether Group 1 Automotive at around US$353.67 is a bargain or fully priced, the key is to understand what the current share price implies about the company’s value. The stock has moved 3.6% over the last week and 6.9% over the last month. Year to date it shows a 9.9% decline and a 13.8% decline over the past year, set against longer term returns of 63.3% over three years and 115.7% over five years. Recent coverage of Group 1 Automotive has focused on the company’s...

Wondering if Penumbra at around US$325.33 is offering you real value or just a rich price tag? This article walks through what the latest numbers actually say about the stock. The share price shows a 1.4% decline over the last 7 days and a 1.1% decline over the last 30 days, while returns stand at 5.1% year to date and 9.9% over the past year. Recent coverage around Penumbra has focused on its position in the medical equipment space and how investors are weighing growth potential against...

At the April 2026 AACR Annual Meeting, Nurix Therapeutics reported new preclinical and early clinical data showing progress across its targeted protein degradation oncology pipeline, including programs aimed at pan-mutant BRAF, CBL-B, and Aurora kinase A. Beyond individual drug candidates, the presentations underscored how Nurix’s induced proximity and protein degradation platforms may overcome resistance and pathway limitations that challenge traditional cancer therapies. With this context...

Artisan Partners Asset Management (NYSE:APAM) is signaling a push into acquisitions and new investment strategies in differentiated credit, private equity and real assets. Management has highlighted an active M&A pipeline, interest in both individual hires and larger deals, and continued R&D efforts to expand the firm’s platform. The company plans to pursue these opportunities while keeping significant excess capital available for potential transactions and organic growth...

Ensign Group (ENSG) just posted Q1 2026 results with revenue of US$1.4 billion, basic EPS of US$1.73 and net income of US$99.7 million, setting the tone for the new fiscal year. Over the past five quarters, revenue has moved from US$1.17 billion in Q1 2025 to US$1.39 billion in Q1 2026, while quarterly basic EPS has increased from US$1.41 to US$1.73, with trailing twelve month net income at US$363.4 million. With net profit margins over the last year near 7%, the focus now is on how...

For readers wondering whether Provident Financial Services at around US$22.38 is still offering value or if most of the opportunity is already priced in, this article walks through what the current numbers suggest. The stock has recent returns of 0.1% over 7 days, 5.2% over 30 days, 13.3% year to date, 37.6% over 1 year, 67.1% over 3 years and 13.2% over 5 years. These figures naturally raise questions about how much upside or downside might be left. Recent news flow around Provident...